Literature DB >> 24311864

A study on the inhibitory effect of polysaccharides from Radix ranunculus ternati on human breast cancer MCF-7 cell lines.

De-Li Sun1, Han-Bing Xie, Yun-Zhan Xia.   

Abstract

The objective of this paper was to study the in vitro anti-breast cancer activity of polysaccharides from Radix ranunculus ternati. Different concentrations of polysaccharide extracts were selected, and MTT assay and flow cytometry (FCM) were used to investigate their growth-inhibitory and apoptosis-inducing effects on human breast cancer MCF-7 cell lines. Radix ranunculus ternati polysaccharides had varying degrees of effects on the growth of human breast cancer MCF-7 cell lines, and the differences were significant compared with the blank control group. FCM showed that the polysaccharides can induce apoptosis. In addition, it can also enhance NK cell activity. Radix ranunculus ternati polysaccharides have a relatively good in-vitro anti-breast cancer activity.

Entities:  

Keywords:  MCF-7; Radix ranunculus ternati; polysaccharides

Mesh:

Substances:

Year:  2013        PMID: 24311864      PMCID: PMC3847379          DOI: 10.4314/ajtcam.v10i6.6

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  1 in total

Review 1.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

  1 in total
  5 in total

Review 1.  Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions.

Authors:  Da-Cheng Hao; Chun-Nian He; Jie Shen; Pei-Gen Xiao
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

2.  Ranunculus ternatus Thunb extract attenuates renal fibrosis of diabetic nephropathy via inhibiting SMYD2.

Authors:  Weiwei Xu; Rui Peng; Siyu Chen; Congcong Wu; Xiaoxiao Wang; Ting Yu; Jiuying Jian; Ni Zhang; Siyang Zuo; Min Chen; Bing Guo; Lirong Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

3.  Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients.

Authors:  Lijing Jiao; Changsheng Dong; Jiaxiang Liu; Zhiwei Chen; Lei Zhang; Jianfang Xu; Xiaoyong Shen; Jiaming Che; Yi Yang; Hai Huang; Hegen Li; Jianli Sun; Yi Jiang; Zhujun Mao; Peiqi Chen; Yabin Gong; Xiaolin Jin; Ling Xu
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

4.  Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size.

Authors:  Xueyu Zhao; Xiaojun Dai; Shanshan Wang; Ting Yang; Yan Yan; Guang Zhu; Jun Feng; Bo Pan; Masataka Sunagawa; Xiaochun Zhang; Yayun Qian; Yanqing Liu
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-25       Impact factor: 2.629

Review 5.  Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer.

Authors:  Li-Rui Sun; Wei Zhou; Hong-Mei Zhang; Qiu-Shi Guo; Wei Yang; Bing-Jin Li; Zhi-Hui Sun; Shuo-Hui Gao; Ran-Ji Cui
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.